Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well dog, it's now been 10 trading days I count on my chart, since it broke the 50 DMA (.036). And the down days have been on higher vol than the "up" days since then (the days where the broker/dealer IMO closes it "flat" at end of day on a lousy $500 order for instance- after it's traded down the entire day). It hasn't made even a break to the 50 DMA avg since, in those 10 days now. That's a down trend and weakness in my book. It's making what I call lower highs and lower lows now- a down trend and weakness IMO. Also, volume on several days is getting much, much lighter- it's drying up IMO. Which on this thin a traded stock- usually means a big down day can come in a blink, if the past is any indicator.
Next stop would be the 200 DMA at about 2 cents or just under that. Barring any pump or similar, I'd venture that's where it's heading IMO, based on a 2 yr, 2.5 yr chart of these similar, past, shall we say "events".
As to trials progressing or similar- I can only say, and always only go by what's in, or what's not in the SEC filed 10-K or 10-Q only. That's why I noted that the Q1, 10-Q is due out here pretty soon - say approx. two weeks. My opinion, if the "big" MIRROR trial gets another "barely mention" as it did in the big, touted, "here will be the big news", end of yr 10-K (or as many "claimed" in the ole "blog", which didn't happen), then I'd say big trouble is a brewing, as in it's not progressing or moving forward at all, IMO (as in no funding and/or other "problems"). It will be one of the first things I look for in that 10-Q. I've always said; PR, "blogs", "tweets" whatever, don't count for much in my book and in my opinion- the document that "binds um" legally- is that SEC filing. If it ain't in there, or if it is in there, good or bad, that's the words/wording that matter IMO. It's all that really counts in the end IMO.
My opinion- is most on here, and elsewhere, never even really read the 10-K or 10-Q or similar SEC filings, cover to cover, let alone really know what most of it says or means (and I'm not claiming to be an expert, or forensic accountant or anything by a long shot- but I can take a pretty good crack at, at least trying to decipher pretty well what it says and means, and read every line, cover to cover, IMO). It's not exactly light reading, and if one has no financial or decent biz background- they can't follow a lot of what it's really saying IMO. They read the Yahoo or similar "summary version" (like a Reader's Digest condensed highlight release) one or two paragraph version- and then "think" they just read, what in reality is a 40 to 50 or more page, pretty complex document.
So, next up is the 10-Q release on the calendar for me. Share count (dilution), cash on hand- probably their most critical number IMO, MIRROR going anywhere or not, "financing" and at what terms- as in, are there more floorless convertible deals like ASHER being used to keep cash essentially "trickling" in, and past "PR" such as middle east "deal" or similar- do they get mentioned in 10-Q, and what have they or are they amounting to- as in sales, revenue, progress, etc.
Many, as I've said before (Pr's and "deals", etc, IMO)- I've looked for many times, and never seem to find um again when it comes to SEC document time (and I'm talking about stuff going back years, across multiple CEO's- about "big" stuff gonna supposedly or "potentially" happen- then just lost when the 10-K's or 10-Q are read later, say 6 months or a yr later, just never heard about again, IMO). They just sort of "vanish" and aren't heard about again IMO. Of course, that's why you always put that ole SEC disclosure language, legal-eze at the end of every PR when speaking of these "deals" and so forth- you know.
I've mentioned the "middle east" one, as in my opinion, it's a perfect one to look for in future 10-K's and 10-Q's to see what it "amounts too", if it ever amounts to anything. Here is the link- see how it sounds "big" and wow, and it must be going to bring in something "big" and all, that's my read IMO. What I found interesting, was I found one way back (a PR), under a previous CEO, about something very similar- a "deal" in middle east countries, but was it ever heard about again?
Here's the one I'm talking about now:
http://www.marketwired.com/press-release/bioheart-announces-agreement-with-anosis-to-distribute-products-in-the-middle-east-otcqb-bhrt-1844922.htm
I want to see what this "deal" has become- is it mentioned in the SEC filings, are revenues coming from it, is it turning into "big" things- cause the "PR" sounds great, right? That's my opinion. But what is it/will it really become? Don't know? And of course the end of the "PR" always has the ole "disclosure" - so if it never amounts to anything and doesn't go anywhere, well, then they're all "covered" via disclosure. Here's what it always says at the end of these "PR" announcements:
"Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2012, and its Quarterly Report on Form 10-Q for the quarter ended June 31, 2013. "
There's the ole legal-eze. Thus, if that great sounding "PR" never goes anywhere, never amounts to anything, it's all been "covered" in the, "we told you the risks" statement, IMO. But that's one example- I'll be looking for it in the SEC doc. What has become of this "deal"? Revenue? Sales? Expansion? Anything? See? The "PR" sounds "big"- but is it amounting to anything? Who knows IMO?
10-Q, next "big" event IMO. We'll see I guess.
10-Q, for first qtr 2014, should be out around 5/10/14 or there abouts, based on prior 10-Q releases.
First numbers I'll be looking for are cash on hand (balance sheet cash line entry), and new, total outstanding share count (dilution), usually on page 1, bottom of page. Should be able to determine then how many shares have been diluted/added since Dec. 31, 2013 10-K date.
Will then use search feature for name "ASHER" and look at any "financing" deals done since 10-K (will look for any names besides ASHER too; will just be looking for floorless, dilutive "financing")- to see what the terms were, for how much cash brought in, how steep a discount on shares, dilutive, if floorless convertible or not, etc
Will look for anymore "in the money" warrants potentially being issued and also if more "vesting ASAP" options have been granted- stuff like that.
Will then use search feature to look at "trials" and see if any update is given on MIRROR, or any other phase II/III trials for that matter.
Will also look for all past "deals" and "partnerships" or similar terms used in approx. 1 yr of past "PR" (middle east "deal" for example) and similar from the "PR's" to see if they are a) Are they even mentioned and b) What have they amounted to- any revenue from them, etc.
Then just read cover to cover to see if anything "new" pops out.
That's what I'll be looking for. Looking forward to it. Should be a good read IMO.
Does the company or "whoever" is running this "promotion" - do they really think it adds "credibility" to the business and add even a micro iota of legitimacy to them?
I mean really? It's laughable IMO. Is this what that company they hired in one of the PR's - is this what they do? The big "promotion" company they put some PR out about a while back? Is this them? And does "tweeting" and "facebook" add any cash, to the cash poor balance sheet? Really?
Again, this is like a bad joke IMO. The common shareholders should be embarrassed IMHO. "bud fox" (a character from the fiction movie Wall Street and a bunch of other dudes with penny site promotion links built right in, repeating verbatim, the same nonsense for over a week now, same statements just cut n pasted over and over?). After about 47 times, I think everyone has seen the "cut n paste" nonsense off the company web site, they know what Myocell is "supposed" to do (no patent by the way), they've seen all the old news "PR's" repeated ad-nauseum, the "it's power hour" and "it should break out big anytime now", and the "chart looks great" (it's horrible in reality IMO) and blah, blah, blah.
Really, this is what "builds a business" or adds cash to your cash-poor balance sheet, or would attract legit, large "investors"? If I saw this penny-ville "stuff", I'd be running for the exists. The credibility is at an all time low in my opinion. This "promotion" being a sign of desperation IMO.
Funny, IMO how one just "finds" these "articles" instantly- in some obscure, local paper? Did BHRT email it to one?
Just curious how this "works"?
Who would just "happen" find that article, the instant it's published, unless someone "alerted" them IMO?
" BioHeart is a well-led company"??? Huh? It's a sub 3 cent stock, debt laden, 3 employee's left, not a single "success" in it's history, horrible IPO, multiple CEO changes, BOD nearly all departed since IPO, nearly cash broke, no sales, no $118 million down the drain, stock price a straight down slope from day one, already financially in trouble at time of one of the worst IPO's in market history, going concern in 10-K from own auditors, defaulted on a key BofA loan nearly sending um to BK, highly diluted stock as in doubled the outstanding shares in less than 1 yr from 190 million to now 460 million and just increased allocated to 2 billion on a 3 penny "company.....??
Man, if that's "success" and "well led"- I'd sure like to see a "failure" or a "poorly led" company?
It's laughable. Guess who has "ties" to ole U. of Florida where the "professor" is from? Yeah?
If BHRT is "well led", I guess the entire public markets and every major pharma and every major "investor" and any buy-out firm, etc all must have missed it- cause as of today it's at sub 3 pennies and has a market cap not even enough to cover it's debt and cash deficit.
Laughable IMO. 3 penny, 3 employee companies who are nearly broke are not "well led" IMHO. Not even close. They just keep piling it on- the ole "PR" machine.
"I have seen lots of negative PR on this company on this board and others "?? Huh? Where? When?
Please cite specific examples of "negative PR", especially "on this board" (which would mean I-HUB)?
Or, do you mean, another vast "conspiracy theory" wherein, any opinion, any statement of fact, any viewpoint different from your own, any citing of the management's own words from a 10-K or similar SEC filed document = a supposed "negative PR" and is part of this imagined "vast conspiracy" against a 3 cent stock, that got to 3 cents, via 100% of it's management's own doing, decisions and own actions, IMO?
What/who has been "trying to harm this company's reputation" in this vast conspiracy, IMO, 100% imagined vast fantasy? Again, where, when, specific examples please?
It's on the OTCBB, has 3 employees left, is loaded with debt, has no products or sales essentially, has nearly no cash on any given month per their own 10-K, has lost about 99% of its value since its horrible IPO, was delisted from a major exchange only about 1 yr after the IPO and going public, has no patent on its "flagship" product, has trials that stalled out and gone nowhere since 2009/2010, and on and on and on? What help is needed to add to their "reputation" IMO? Their own 10-K's and similar filed documents, pretty much "tell the story" that anyone would want to know IMO (no sugar coating needed). Or, perhaps, is it the near endless string of "PR's" going back 4 or more years, most of which never somehow appear to come true, or never come true, or never appear to be heard about again in a later 10-K or similar, or ever amount to their vast claims being made in them. Is that the fault of a person who links to them and points something like that out?
Kinda like that?
Or, just pure conspiracy theory nonsense being conjectured here, IMO. They are where they are today IMO, 100% via their own doing. No one has needed to "help" them along to being a cash poor, debt loaded, 3 cent stock IMO. Management/the insiders run the show, and have all along since day 1. At least 3 CEO's in about 5 yrs, mass departures from the BOD, nearly every employee they ever had was laid off or fired or let go, Northstar is of their own creating/making, every "finance" deal they ever entered into, they did on their own and signed on the dotted line, etc. Management- they drive the ship, they make the decisions, they've gotten it to where it's at today. No one else to blame or implicate and no vast conspiracy theories needed in my opinion. No more complicated than that, as I see it.
Gs, anything is possible. When I state they "willingly did it" - I'm not saying they did it cause they liked it. They had to go to those "lenders of last resort" to hang on.
And as you state, the unfortunate side of that is, a) Dilution typically, lots of it and b) Getting your stock/company now wrapped around the axle of some of the most brutal dudes and finance houses on the street. I don't need to post it again- you've seen that I-hub page someone put together on ASHER and the history/demise of how many companies who got involved with them. And also, the article I sited previously where they show, step by step, how these ASHER type folks do what's called the "ratchet" short, stepping it down, cover, stepping it down, cover, all the way to the bottom, and because of the "floorless convertible" shares and the steep discount they get- the lower they can make it go, the more shares they get, then more money they make.
I stated before, these aren't dudes looking to get a CD rate of return or even Venture money rate of return on their coin(say 25% return on their money) - these guys can make 200% or more on these deals- and turn their money over as fast, and as many times as they possibly can.
And yes, I believe they either a) Often have a "broker/dealer" wing/division that sits right under their own roof with high speed trading desks going right onto the "networks" or b) have close relationships with several "trading/order routing firms" - to whom they then get "commission" type relationships going for routing/sending their order flow to them; the I scratch your back, you scratch mine type deals.
So, the entire thing = collusion type deals where they can yank a stock, especially a penny, where the daily dollar volumes are low (think BHRT, even at 1 million shares a day, at 3 cents is only like $30K traded, like qty-15, $2000 trades in an entire day)- so think of the power these guys can have. They can toss up, as you stated, "orders" onto the network- say "flash" a buy or sell of $2K and swing the stock the way they want it to go- and they open up the spread, either up or down IMO, depending on what they're trying to do. They have a lot of money at their disposal- so lets say they want to move a thinly traded stock, what would it take? Maybe they start tossing up a few $1K or $2K orders to sell, their own, here and their, using their own money- incite a little selling panic, and next thing you know it just tanked 18% in a blink like we've seen, they cover perhaps a short, and just went to the bank.
It's been discussed in many books, there's Youtube videos, 60 minutes about 2 weeks back had a guy talking about electronic networks and how it's all 100% "rigged" now, in his words. Who the heck knows exactly how they "do what they do"- but I don't think for an instance this thing went from about 2 cents, dipped to .0063 or whatever, then not far from that, shoots to .08, then crashed the next 2 days to as low as .025 or something, then back to .06, then now back below .03 and so on- no way IMO this is all "chance" and just "normal" retail folks buying and selling as actual "investors". Let alone look at this recent- you know, "stuff" being plastered "commentary" everywhere, you know, the "wall street movie" dude appearing out of nowhere- and stating all this stuff copied off the BHRT web site, like 8 times in 3 days? What the heck has happened/caused all that? The word used is "promotion"- but for what purpose and why and by who? It sure doesn't add credibility and stability to things IMHO.
And the worst of the worst of course- is if/when they decide to turn and go short. It's only professional level houses that can short a 3 penny stock. And an ASHER is motivated to go short- again, because on "floorless" convertibles, the lower they can get the price to go, the more shares they get when they convert (see the 10-K for the conversion formula- it'll say something like, "based on the avg of the lowest 3 days prices, in the prior 10 day trading period, blah, blah, blah) -anytime you see that, it's a "floorless" or "toxic" convertible, because the lower the price goes, the ASHER type dude actually gets more shares when they convert. It's like being "The House" in Vegas. They've rigged the game so they can't lose. Other than the firm going BK, the ASHERS of this world always make out- cause if the price goes up they make money- and if it goes down, like way down and they're short, they can make even more boat loads of money.
It's a bad deal. There has been talk for a long time of the SEC trying to reign in this particular type of practices- but my personal 2 cents on the SEC, is good freaking luck, I think they're in on all this "stuff" as much as anyone. Like politicians- you pay the right guys a "fee" or "campaign donation" or whatever, and everyone turns a blind eye.
Once on the OTCBB- it's tough sledding, no doubt. Why someone hasn't stepped up to finance um? Don't know? I started reading 10-K's and stuff clear back to the IPO period, and IMO and what I found, they were really already having some pretty bad financial problems clear back then- going on 5 yrs now. They had millions at one point- but were already showing all the signs that bad things were coming- loans, loans with problems, insiders starting to need to chip in to "cover" shortcomings, etc. So, it's a technology maybe just not ready for prime time yet- many would probably argue they never should have gone public at this point. Maybe should have stayed at a laboratory/research level longer? Don't know. I guess they wanted to go right to "trials" and we all know, "trials" means you need some pretty big coin.
As low as the market cap has gotten on several occassions (even now it's a paltry $12 million or something)- someone could have stepped up and bought the entire thing out for a a song IMO. But no one has- don't know why. I mean, lets say it was even like a $25 million offer or something- in the world of public markets and finance, that's noise level money really. Shoot, Yahoo or Google and folks like that- they buy companies from "teen kids" all the time for money like that. Some freaking software gizmo app- that some kid cooked up, and you can read where Yahoo, or Google or Facebook or something bought it for like $20 million, like it was a petty cash drawer level deal.
So, don't know? Your speculations are as good as any. Don't know if investors think it's too early on the technology, or don't like/believe the tech is going to pan out, or at least not for years, or if they're afraid of the "patent" stuff, that some 10,000 Lb gorilla like a Baxter will just come in and stomp um out? Many possible theories- don't really know?
Manipulation via people who BHRT mgt willingly did deals/financing with.
That's the part that one can't leave out. It's of their own doing. They inked the floorless convertible share deals with the "ASHERS" of this world, they, mgt issues the boat loads of "in the money" warrants, they dilute the shares- it's all under their command.
If the company wasn't essentially broke, and broke for a long time now- they wouldn't be in this predicament IMO.
But the underlying basis of "how did it get here" and "why is it a 3 cent massively diluted stock" is 100% management's doing- no one else.
They just filed to up the outstanding shares to 2 billion- so they're "doubling down" to use the ole Vega term. It'll only get worse IMO.
a) BHRT didn't close "higher" - it closed perfectly "flat" and has for 3 trading sessions in a row, all after trading down all day, then a micro trade ($500 say) at the end to "walk it up" to close even.
b) The DOW was down big today, S&P down almost 1% and the NASDAQ got hammered. So, don't know about the supposed "mid-cap and large cap" all "closing higher" in the minutes (not even sure what in the minutes means?)?
Pennies and micro-micro caps are often, more than not, heavily manipulated- it's no mystery or secret. Several on here even use the term "MM" (market maker) when referring to penny stocks. There's no such thing. There are broker/dealers who can route order flow, try and match order flow, onto several electronic networks that allow trading in pennies. Often, the same one who is "financing" a penny like BHRT (ASHER for example) also has in-house, or at least a close relationship with a penny broker/dealer who will handle their order flow for them. That is how the OTCBB and pinks "work" and there is zero comparison or relationship to anything listed on a major exchange and especially a mid or large cap stock. Might as well be on two different planets.
Manipulated close again. Trades down all day- then, right at close, they "walk it up" on some tiny, maybe $200 to $500 buys at most. Someone is really, really "working" this thing IMO.
They're still unloading a chunk, selling some of those "in the money" warrants, or whatever for a large client/insider or something along those lines IMO. I think at some point- they'll turn short (ASHER or similar), or someone will dump a boat load, and it's gonna tank in a blink.
The trading pattern is just too "same" for a week now- plus of course the "other" coordinated "stuff" that's obviously going on, like the light switch was "flipped on" and the "go command" given.
Penny-ville to the tee, IMO. All this PR though- and they can't even get it back, close to the 50 DMA, not a good sign IMO. It's "PR'd" out the way I see it.
The manipulated closes are just too obvious though. Down all day, well down, then literally, 5 minutes to close and a few micro order "buys" are "painted" so they can close it "flat" on the day. The broker/dealer handling this, has it pegged IMO.
"Bioheart's MARVEL Trial Published" CHECK THE DATE.
Marvel hasn't gone anywhere in over 4 yrs now. Is this the "old news" outlet?
Latest 10-K, PAGE 2.
The last "update" or progress I'm aware of on MARVEL goes back to about the Sept, 2009 presentation of data, and that was only on 20 patients so far, out of over 100 needed. It's never progressed again beyond that, that I am aware of?
So, actually make that close to FIVE yrs old now.
"We are seeking to secure sufficient funds to reinitiate enrollment in the MARVEL and REGEN trials. "
That word "reinitiate"- as far as I'm aware, via looking in a English dictionary, means they need to "re-start" them, because they are presently STOPPED, going nowhere, not "progressing", etc. Something that is already in-motion, or "moving along" does not need to be "reinitiated" cause it never stopped IMO.
"finally very close to the finish line."? Huh? What "finish line"?
They don't have a single product/process that I'm aware of that's even remotely, not even a far distant chance IMO, from being close to even "submitting" something to the FDA?
They've not even completed a phase III trial, nor to they appear to have a phase III trial even progressing right now. not one? So what would be the "finish line"? Further, even if something were to ever reach "submission" to FDA, it by no means = approval.
Have no idea what the "finish line" would be, or is even supposed to mean? They are cash poor, 3 total employees left, and nothing I'm aware of even remotely close to being ready to present to the FDA?
Is there a 10-K that could be cited that would indicate this "finish line" is "close"?
Look at a "typical" (IMO) phase III "stem cell" trial from an enormously successful company, Baxter, a true "world leader" in healthcare, bio-tech, and medical technology with about 60 THOUSAND employees and easily a $billion dollars at their disposal. They list 4 (four) years to even expect "final data" on their stem cell, phase III trial. Not an FDA "submission", but just the conclusion of the trial and "final data".
http://clinicaltrials.gov/ct2/show/NCT01508910
Enrollment: 291
Study Start Date: April 2012
Estimated Study Completion Date: June 2016
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
That, IMO is "typical" and being done by a world leader, who obviously knows what they are doing, and has an enormous, R&D budget and enormous staff or highest caliber research scientists and entire departments of nothing but FDA regulatory specialists. 4 yrs to "final data" is what they are stating.
That's what I see and IMO, BHRT is not even close to any "finish line" for anything?
Volume looks to be drying up. Going on a week plus now, and never came close to breaking back over 50 DMA, despite the PR barrage.
It's in a solid downtrend now according to the chart.
IMO, one major sell order of "size" or shorting campaing from an "ASHER" type or similar (a lot of convertible shares sitting out there IMO = short at some point in future), or some insider type, or warrant holder or whatever selling a chunk to make some money- and it'll have some more 10%, 15% or 15% plus down days like we saw fairly recently.
Right now, it's just the broker/dealers working with someone still IMO- to hold the price here as I see it trade daily. Everyday, it's spent most of the day down, then right at close, they've opened up the spread and closed it out to look "flat for the day" on one, or a few, tiny buy order. That buy could very well be "them", some broker house, "walking it back up" to suit their own needs. It's net selling everyday IMO from what I've seen.
At some point here, I think it heads for the 200 DMA area of about 2 cents. The "PRs" recently, have been blasted out nonstop, nearly some "announcement" every few days, seems to have lost its ability to pump the price up IMO. "PR fatigue" is how I see it.
Not to mention the "other" hype going on, all day, every trading day for over a week now- has had zero effect to move it, IMO.
Wow!, Gee ! "The six month data has far exceeded our expectations."
Want me to link to every "PR", oh, lets say going back 4 yrs to shorten the list- that says something nearly identical to that?
PR that is loaded with "far exceeded" or a favorite word, "breakthrough" or similar?
Got an entire link list built- it was getting so hard to keep track of um. IMO, for a 3 cent, penny stock- they put out more "PR" than probably Apple for example. I can probably count the PR releases from someone like Apple or the company Facebook for example- and be able to prove, IMO, that BHRT puts out at least, if not more "PR" releases.
The big "news" today- doesn't seem to be moving the ole stock price too much? Sometimes, you just wear out the "PR" machine IMO. Further, vague statements like ""The six month data has far exceeded our expectations." don't do much for me personally anyways. What were the "expectations" in the first place as compared to what current, peer reviewed research "norms" and then what scientific methods were used to figure out they "far exceeded" these "expectations" and so forth?
It doesn't say or mean much IMO as stated. Just more "PR" IMO. Make of it what you want. If you find it "exciting" or whatever- more power to you. Where's the phase III "trial(s)" as in multiple that we never hear about anymore? A 5 person, phase I in Mexico? What's the point IMO, when your phase III has gone nowhere? What's this phase I supposed to amount to now? You've gone backwards IMO. If you can't "fund" what you have on your plate now, that was far advanced of this 5 person phase I, then what is it going to cause to happen supposedly?
Buy, sell, hold, get excited, whatever one wants. To me, does nothing for me. Not "exited" in the slightest. Read so many similar "Pr's" with similar wording that went nowhere later on. I'd be more interested/concerned about the form 14, SEC proxy filing that somehow never made it on the old, big "PR" circuit. Kinda odd IMO, the "selective PR" thing. You double your outstanding share count, and the common holder have no say or vote in it, and it receives zero "PR" or big announcement? But every other trivial (IMO) "event" like someone getting and "award" or giving a "talk" is blasted out, all over every PR outlet you can find? Yeah. OK. Again, get excited if one wants. Good luck.
Or NO "Partnership or reverse merger???" perhaps?
Lets see, a phase II/III trial has sat for 4 yrs now and never attracted a "partner" and don't even know what a "reverse merger" is supposed to be or mean?
But years of FDA, actual inside the U.S. "trials" did nothing for them, and amounted to nothing- except of course, massive share dilution and a collapsing stock price, essentially straight down to 3 cents.
But now, now today , suddenly, a 5 person "trial", done in Mexico is suddenly, as has been stated probably 500 times, going to cause "something big" to happen?
Why IMO? Why now? What's different now than last yr, other than more shares being out, twice as many for the most part- 190 million to now 460 million plus?
I don't see a single fact, or material event or "cause" now, that's any different than any number, numerous numbers of "PR" and similar I can dig up, going back over 4 yrs, that never caused these "claims" and conjecture and IMO pure "hype" to ever materialize.
Not seeing it. That's my opinion. Just dreaming and conjecture based on nothing of substance really IMO. If a phase III, that was actually a legit, FDA regulated, inside the U.S. trails didn't "do it" for um, what's going back to square on in Mexico, with 5 people, no cash essentially, no employees really left (3 total) and more share diluted than ever, going to cause "it" to happen now? Don't think so IMO.
IMO, by the time the 10-Q comes out, just read page 1 and look at the share count and figure out the dilution, then look for the cash balance entry. That's about it, IMO.
Totallycomfused- wow is all I can say. Thanks for sharing the info- it's totally understandable IMO to want to limit what info is put out there.
I have no reason IMO, to doubt that you're "for real". Why would someone suffering COPD, looking for a solution, go to all the trouble to create all this pretty detailed info and post it IMO? Plus it appears to have enough details to be pretty easily verifiable IMO.
I'll have to read it several more times. Probably want to do some more research on my own too- but it's some pretty "amazing" stuff said in there IMHO, to say the least.
My opinions only, and only related to reading what totallycomfused has stated. It's for our own discussion and not meant to make anyone buy, sell, hold a stock or influence anything they think about any company or stock. It's opinions only and information only as far as I'm concerned. Do your own due diligence and make of the discussion/info whatever you want. My thoughts or statements are mine only and not intended to influence anyone else. Read um or ignore them or do with them what you want. Opinions/musings/observations only- nothing more.
And here's the FACT based "update":
Latest 10-K, PAGE 2:
"We are seeking to secure sufficient funds to reinitiate enrollment in the MARVEL and REGEN trials. If we successfully secure such funds, we intend to re-engage a contract research organization, or CRO, investigators and certain suppliers to advance such trials.
"
"Reinitiate enrollment" in plain English, means that presently, "enrollment" is NOT going on. No more complicated than that.
The word "reinitiate" means to "re-start" something that is presently stopped.
That, is the factual "update".
"
Funding will be made available if not already..."?? Same 10-K, they have $46 THOUSAND total dollars left to their name, end of 2013. They added a supplement to the 10-K prior to release that brought their cash to a grand total of about $211K dollars.
That doesn't even cover maybe one month's, 2 month's tops- "burn rate" and spending. No more complicated than that. They are essentially "cash broke" on any given month, any given time period. There is zero proof of some "financing deal" or whatever- other than dumping shares off in enormously dilutive deals to Asher and their ilk or similar- and the cash "trickles in", in amounts to keep the company limping along in one to two month or so intervals.
That's what the 10-Q's and 10-K's say- as they state the qtr to qtr cash balance situation- and it's dismal at best, each time, for over 2 yrs. Life support dismal- and their own mgt comments and auditor "going concerns" statements, among other statements in the 10-K or 10-Q's essentially say/admit that.
Those are the facts IMO, not opinions or "blog talk" or whatever- just reading the SEC docs. Nothing else is needed IMO, if one wants to know the true condition of the company.
"Tomorrow BioHeart presents" Yaaaawn.
A "phase I" of 5 people in Mexico,a big whoop IMO.
Hey, how bout those "lost", big ole phase II and phase III "trials" that just seem to have vanished?
Any updates on those? You know, MARVEL for instance, gone nowhere in what, like 4 plus yrs now?
Any mention of MIRROR- other than the "barely mention" in the latest 10-K?
5 people, phase I, outside U.S. at some facility in "Mexico"- sorry, but for me personally, doesn't do a thing. Nothing. That's my opinion. Phase I means what, another 5 yrs to as much as 7 to 10 yrs maybe to complete the phase II and then phase III, if, the big "if" they even attempt to get it through the FDA gauntlet?
That's my 2 cent opinion. Just another "PR" event IMO. That's about it, the way I see it.
"I have never seen a .03 stock that was on the NASDAQ before"?? Huh? What?
That's like stating that being DELISTED is some "badge of honor" or something? It's a sign of a failing company. You don't get delisted cause things are "going great", that's for certain.
Nearly ever penny stock in existence (except for total, criminal level sham/scams using empty shell corps and similar)- every one that ends up on the OTCBB or "pinks" was once a "listed company".
BHRT barely lasted 1 yr on the NASDAQ. They were in horrible financial condition, weak financial condition even when they went public- in one of the biggest "bust" IPO's in at least modern stock market history.
http://venturebeat.com/2008/02/19/three-yards-and-a-cloud-of-dust-bioheart-makes-it-across-the-ipo-goal-line-but-with-little-to-show-for-its-struggles/
http://globenewswire.com/news-release/2009/02/26/393349/160467/en/Bioheart-Inc-Receives-Notice-of-Delisting-From-The-NASDAQ-Capital-Market.html
http://venturebeat.com/2007/10/12/i-told-you-so-eat-your-bioheart-out/#comments
"always SOARS on a FINACIAL deal"?? (it's financial, spelling) Huh?
Pull up any chart- 2 yr, 3 yr, 5 yr??
The stock is STRAIGHT DOWN to sub basement level (sub 3 CENTS) since one of the worst IPO's in stock market history.
The stock has never "soared", ever IMO? It's down over 99% from the IPO date.
" A/S increase has had minimum effect on the PPS "?? The stock has been diluted from over $1 dollar a share, even several dollars a share to THREE CENTS. It was delisted off the NASDAQ after only about 1 yr of trading- sent packing the OTCBB.
Don't know what info you're talking about or what chart you read or look at?
Tomas has been in the driver's seat since what, about 2010- over 4 yrs now I believe? The stock price is STRAIGHT DOWN from the time when he took over. I'd need to look at a chart- but I think it was at least 50 or 60 cents, if not more, when he took command. And under his watch, they've never secured a "major financing" deal that I'm aware of in the past 4 yrs or so? They've only massively diluted and used some of the worst "financing" and "financing of last resort" a company can use while on his watch- diluting shares from about 20 million shares in 2010 approx, to now over 460 million as of that form 14 just filed.
That's facts, versus pure speculation, conjecture, etc IMO.
"Biotech Investing for Beginners " IN THE REAL WORLD.
CASH and lots of it. Simple as that. No CASH, no existy anymore. What, use monopoly money? Read the latest balance sheet in the 10-K.
Or here, read this: Latest 10-K, PAGE 25 and 26-
"
Risks Related to Our Financial Position and Need for Additional Financing
We will need to secure additional financing in 2014 in order to continue to finance our operations. If we are unable to secure additional financing on acceptable terms, or at all, we may be forced to curtail or cease our operations.
As of March 24, 2014, we had cash and cash equivalents of approximately $211,632.80 and a working capital deficit of approximately $13.4 million. As such, our existing cash resources are insufficient to finance even our immediate operations. Accordingly, we will need to secure additional sources of capital to develop our business and product candidates as planned. We are seeking substantial additional financing through public and/or private financing, which may include equity and/or debt financings, research grants and through other arrangements, including collaborative arrangements. As part of such efforts, we may seek loans from certain of our executive officers, directors and/or current shareholders. We may also seek to satisfy some of our obligations to the guarantors of our loan with Seaside National Bank & Trust, or the Guarantors, through the issuance of various forms of securities or debt on negotiated terms. However, financing and/or alternative arrangements with the Guarantors may not be available when we need it, or may not be available on acceptable terms.
If we are unable to secure additional financing in the near term, we may be forced to:
· curtail or abandon our existing business plan;
· reduce our headcount; (they only have THREE people left?)
· default on our debt obligations;
· file for bankruptcy;
· seek to sell some or all of our assets; and/or
· cease our operations.
If we are forced to take any of these steps, any investment in our common stock may be worthless.
Our ability to obtain additional debt financing and/or alternative arrangements, with the Guarantors or otherwise, may be limited by the amount of, terms and restrictions of our then current debt. For instance, we do not anticipate repaying our Northstar loan (described below) until its scheduled maturity. Accordingly, until such time,
we will generally be restricted from, among other things, incurring additional indebtedness or liens, with limited exceptions. See “We have a substantial amount of debt...” Additional debt financing, if available, may involve restrictive covenants that limit or further limit our operating and financial flexibility and prohibit us from making distributions to shareholders.
If we raise additional capital and/or secure alternative arrangements, with the Guarantors or otherwise, by issuing equity, equity-related or convertible securities, the economic, voting and other rights of our existing shareholders may be diluted, and those newly issued securities may be issued at prices that are a significant discount to current and/or then prevailing market prices. In addition, any such newly issued securities may have rights superior to those of our common stock. If we obtain additional capital through collaborative arrangements, we may be required to relinquish greater rights to our technologies or product candidates than we might otherwise have or become subject to restrictive covenants that may affect our business.
Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern."
"Going concern" is the "nice" way of saying BANKRUPTCY and NO CASH to payee offa thee ole debts.
"DID YOU GUYS SEE THIS" (dated March 7th)?? A little "old news" isn't it?
"A blog"? Yeah. OK. Is there any cash or "investors" or non-dilutive, non "toxic" floorless convertible "financing" or similar listed in the 10-K or any other SEC filed document or similar?
Funny, the ole "blog" forgot to mention the 2 BILLION share allocation increase they must have known was coming IMO? How'd that little tid-bit of "kinda important" info get left out? How?
If not in a SEC doc, IMO, it means nothing. No more complicated than that. A "blog" that's not even hosted on the official company web site. And it's "vague" at best IMO. I can link to PR's going back 4 or 5 yrs or more- that say essentially, near word for word, those exact same statements about, "a rather large interest in the sector of regenerative medicine, as well as institutional investors." blah, blah, blah. Nothing new being "claimed". Old saying, "show me the money".
I keep a "link list" now, I've found so many.
"Blog" IMO = big whoop about nothing.
If it gets one "excited", or trips their trigger or whatever, best of luck to um.
Good luck and happy trading.
No longer under patent: "Bioheart’s lead product candidate is MyoCell®,...."
10-K, PAGE 30:
"Our product candidates may never be commercialized due to unacceptable side effects and increased mortality that may be associated with such product candidates.
Possible side effects of our product candidates may be serious and life-threatening. A number of participants in our clinical trials of MyoCell have experienced serious adverse events potentially attributable to MyoCell, including six patient deaths and 18 patients experiencing irregular heartbeats. A serious adverse event is generally an event that results in significant medical consequences, such as hospitalization, disability or death, "
Page 40:
"We hold limited patent rights in our product candidates. Our MyoCath product candidate is protected by a patent, expiring in September 2017, in which we have an irrevocable co-exclusive license. Our MyoCell product candidate is no longer protected by patents, which means that competitors will be free to sell products that incorporate the same or similar technologies that are used in MyoCell without infringing our patent rights. As a result, MyoCell, if approved for use, may be vulnerable to competition in the form of products that use the same or similar technologies. "
"angel investors" DO NOT invest in companies that have already gone public.
When/how is Adipocell going to "make money" in "early October"? Can you please supply links to the 10-K or a PR or similar stating that? Some here must not have seen or read that news release.
Thank you.
"Well, I have stage 4 emphysema/copd, so I have researched this over the last years. IMO, you are completely correct about all your assumptions. I actually received an email from the the company with a price quote. "
Firstly, very sorry to hear of your condition. Wishing you the best outcome.
Would find it fascinating to see the body of that email if you can cut n paste it. Would like to read the wording and see how exactly it's stated and so forth.
My personal opinion, and that's all it is, "my opinion" only- is anyone (hospital, clinic, academic researcher, whatever) that states something is a "study" or "trial" or whatever, and then wants to charge a "patient" $1000's or $10's of thousands of dollars to "participate"? Personally, and that is ME only, I'd run, not even walk, to get away from it, again in my opinion. That's just my opinion only.
All "normal", generally accepted practices that I've ever read or heard about or seen reported in "trial" recruiting "notices" (journals, magazines, television, academia, etc) say the "patients" is/will get some sort of "reimbursement" to be a participant- usually some basic fee/rate plus travel expenses, etc. It is not uncommon for cancer treatment "trial" participants to receive "treatments" in which each bag of the drug costs over $5000 a bag, for example, and the trial "patient" is not charged one dime to be "in the trial" and participate in the research.
There are famous stories, of people who, for example, paid their living expenses while in college via being "trial subjects"- just signing up for every research "trial" in which they met the requirements and were thus paid to participate. (will find the link to one when I can- one guy participated in like 100's of drug trials, it was in a very well respected technology mag I read regularly).
Here is a link to the 60 minutes piece specifically on "stem cells" being offered/done "outside U.S." in hospitals or "clinics" or by "researchers" who promised, near "miracle" supposed "cures" and/or "treatments" that were way outside the bounds of FDA approved processes/drugs and/or generally accepted current science and peer reviewed methods. They have a top Duke University, world class known researcher in the interview, she appears several times- in her words she states her estimate is is minimum 10 to 12 yrs away from "any" actual approved, "safe" treatment involving stem cells and the 60 minutes piece was done in 2012. So that'd be 2022 or later IMO?
The 60 minutes story, if you've never watched it- 60 minutes being one of the still, most respected "investigative journalism" organizations in the world:
http://www.cbsnews.com/news/stem-cell-fraud-a-60-minutes-investigation-26-08-2012/
Read the article below it too, it's 5 pages I think, very good info IMO.
Man again, totally sorry to hear about your condition and situation. Be careful IMO. It's easy to become a bigger victim out of desperation and hoping for a cure or "treatment". I've dealt with several family member's w/ bad cancers (fatal in the end) and several other diseases- I similarly, scoured and researched and read volumes on everything I could find on their conditions. So I know how that works.
Some Hollywood cases are real well documented and famous 1) Because they have a lot of money to spend for a supposed "cure/treatment" and 2) They are a few hours drive from the Mexican border and/or travel expenses to them are nothing, as in even using private jets and so forth to rapidly get to where they need to go outside U.S. borders. Steve McQueen, Mexico cancer "treatment" being one well known, well documented case:
http://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/laetrile.html
"During 1980, movie star Steve McQueen attracted considerable attention when he was treated with Laetrile at another Mexican clinic under the supervision of William D. Kelley, a dentist who had been delicensed by the State of Texas after several brushes with state and federal law enforcement authorities. Although McQueen gave a glowing report when he began his treatment, he died shortly afterward."
Here is a link, just as an example, to "Stem cell" studies and research taking place in the Philippines, even they are having trouble with FDA type "regulatory" problems per their govt own standards- meaning doctors/clinics charging for unapproved "trials", etc
http://www.philstar.com/science-and-technology/2013/08/01/1035761/4-medical-groups-stem-cell-therapy-still-clinical-trial
"charging exorbitant fees for these procedures which they said are supposed to be under “clinical trial.”" and it also states,
""“In clinical trial, it is unethical to charge patients for these unproven indications. They (the patients) are actually the ones who should be compensated because they are part (of an experiment),” he added." (govt. physician regulatory person speaking in Philippines)
Here is a statement from a body/group (stacked with M.D.'s and Ph.D. researchers on their stated roster) specifically who deals with stem cells, specifically mentioning "Autologous" stem cells- they discuss "commercial" aspects of "unproven treatments", etc . Very interesting read IMO.
http://www.isscr.org/home/about-us/news-press-releases/2013/2013/09/12/isscr-statement-of-delivery-of-unproven-autologous-cell-based-interventions-to-patients
Here is their quote:
"Despite known risks, the many uncertainties, and the absence of scientific evidence supporting efficacy, some clinics and companies are offering unproven ACBIs to patients for a wide range of diseases and injuries. Many of these “clinics” charge substantial fees to patients, and operate in jurisdictions that have little oversight of medical practice. "
They also specifically discuss the words "for profit" and "ethics" in a paragraph, same article linked above.
Further quoting from them:
"The ISSCR condemns the administration of unproven stem cells or their direct derivatives to a large series of patients outside of clinical trials, particularly when patients are charged for such services."
Those are just some examples of things I've read. Again, one can make of them what they want. My opinions only- only there for discussion in reply to a specific statement about a COPD person who said they were "quoted fees" to participate in a "trial/study" type of "treatment" in Mexico. Do ones own due diligence, research- whatever. N
Never buy, sell, trade stock or form any medical or other opinions, or make a medical decision without one's own physician being involved, and especially based on anything I say or state. It's my information only- for discussion purposes only, linked only to stories, or for example the 60 minutes TV piece that I watched for myself, and myself only. I share the links to those investigative pieces or newspaper published or similar "journalism" pieces because they may be of interest to people who follow this field of medical research and companies involved therein. Do whatever one self wants to do with the information.
Now that - I found very interesting reading. Here is why I personally find it highly relevant potentially:
A personal (what's the word?) I guess "concern/potential problem" I've seen, IMO of the BHRT "trials" is they rely on a large degree it appears, on something like a "walking distance" test as the measure of outcome.
My personal feeling, it that's a tough "science" to use/prove perhaps. Whether you got the real deal, or even in a blinded, placebo study- and you got the placebo- my opinion is it would be hard to get real, confirmable outcomes. Here's why IMO- if you stand someone up (placebo or the real deal injection) and you give um a "test" that involves personal motivation- as in saying, "try and walk as far as you possibly can", the placebo effect can be huge IMO.
It's like a injured vet, or when I used to compete in sports- track, cross country, etc. When you're pushed, really motivated- it's amazing, stunning even, sometimes how much more you can go beyond your limit. When running alone, I could do a time of X, and thought I'd just nearly killed myself and pushed the limit. Put in a race situation, with a competitor running right at your side the entire way, you suddenly could run and maintain their pace, and then, on a good day, kick the end and beat um, and beat your own best time far beyond what you'd ever done previously. You know the stories- the father lifting the back end of the car up a few inches, when his kid is pinned underneath, or a combat soldier going waaaay beyond human capacity in the heat of battle.
The interest in that article you site- what I've more been looking for- is they're using things like "imaging"- they're actually going in, looking at the heart, blood flow rates, scar thickness, whether it pumps more again, etc. Very tangible, emperical, lab type measurements that can be quantified (and as science needs- independently repeated/verified by another, totally separate lab/team facility)- and the patient can't "bias" it or influence it via motivation, personal drive, trying harder, the will to walk farther- in other words, the placebo effect is probably effectively been controlled now perhaps. Very interesting.
I noted they're using some other cell/tech name, "mesenchymal stem cells (MSCs)" - don't personally know the details on what those are specifically yet. Will look them up for sure.
Good article. Very interesting. I like the imaging, quantifiable measurement stuff- I think that's a big plus IMO. Walk testing or similar has always rubbed me wrong a bit- just think it's too easy to have a placebo effect, whether you're in the control arm, or the real injection. The mind is an amazing thing- if you want to "get better" or feel better, you often will- especially when you know you're being asked to perform.
That's my opinion. Interesting though. Nice.
P.S. Look at the pedigree on that study team- loaded with M.D.'s, Ph.D's etc- heavy academia med researcher types. That never hurts either, IMO.
"Concentrate on your strongest and get it to market ."
Couldn't have said it better myself. All my experience in high tech, business, watching stock and companies struggle, etc says:
When you're in tough time, tough going, when money is low, when you're facing all kinds of hurdles- you knuckle down and go back to your CORE COMPETENCY and narrow your focus to laser sharp.
Not, scatter shot all over heck. There are classic, classic text book cases (many used in MBA level courses, in Harvard biz review and similar texts used).
1) Starbucks- had been floundering. Mcdonald and many others stared selling decent coffee- started eating into their market. Starbucks, run by the ole "MBA" mgt, had gotten into selling freaking CD music and schlock and what not. Opened way too many stores and were canabalizing their own locations. They brought back the original founder and CEO, Shultz. He immediately- like a freaking blow torch went into slash and burn mode. Closed non performing stores or ones's too close to other key locations. Dumped a bunch of the schlock merchandizing. Went back to their original cup and logo design and then got focused back on COFFEE- their core biz. Coffee and the "atmosphere" of hanging out at their locations. The stock doubled in less than a few yrs and it's a profit, money making machine again- roaring successful
2) Apple of course- perhaps thee text book, most researched turn around in modern biz history. Literally almost lost the whole deal. They bring Jobs back. He goes right back to making the best, core tech, well designed, highly functional products ever made in their arena. He then goes after the music biz, then the phones, etc- the rest is history. A cash printing machine with probably more, cold, hard cash in the bank that many countries.
There's many more. But the point is well taken- you go back to your core, to what you know, BioHEART (Hearts), I thought was their deal/expertise. You narrow, you pick your best couple candidate products- you put everything you got into um, and go full bore, make it or break it IMO.
The last thing you do IMO, my experience is begin to lose focus, go scatter-shot, drift, throw things at the wall for the ole, "lets see what sticks", etc. That just smells to me, IMO only, of desperation. As in, you're out of ideas, besides being out of money. Not good in my humble opinion. If MIRROR or MARVEL doesn't advance and soon IMO, I'd say it's just gonna be dilution, dilution, dilution for as long as the show goes on- and then one day, "lights out". Down to 3 people- how much can they realistically, possibly really do IMO?
Do your own due diligence, That's my ole opinions and thought and mine only. Read um, flush um, whatever one wants. Don't buy, sell, hold or trade based on anything I say. Just my musings for my own interest and conversation with others who also like to follow stocks and trade and so forth.
"They also charge their trial subjects a rather large sum on money"
That is my understanding too- from things I've read and seen on the net. I believe you are more than likely correct IMO.
Thus, to call something a "clinical trial" in the classic sense of what most are familiar with- as in U.S. based trials, where it is quite common for the patient to be paid a compensation (basic fee, travel, etc) to be willing to be a participant, versus being charged a fee- well, many find that outside the "normal" bounds of what stands as typical "clinical trials" IMO.
My understanding, again, only my opinion from 3rd party sources/research (the 60 minutes piece being probably the most highly regarded, well known, highly viewed)- is that it's not unusual at all to be charged $10K, to maybe $20K a pop for a "treatment" and this, from my understanding would/could fall under the heading of being a "trial participant".
In other words, in the opinion of some, it's possibly being used as an attempt at a "money maker", versus true "research" in the classic sense and understanding- especially where it's medical and/or academia related.
Thus, I believe IMO, (my OPINION ONLY- not claiming to have hard facts regarding this particular trial or "study" or whatever one wants to call it)- but that the particular clinic/hospital (The one in Mexico and other latin/central american locations) and especially "stem cell" related "procedures/treatments/studies" - whatever term one wants to use, often do come with a fee to the "patient/study" participant, and it's cash on the barrel head from the things I read and viewed.
So, I believe you are more than likely correct IMO. It also dovetails with several, fairly recent "PR's" where they (BHRT), appear to be getting into the "medical tourism" stuff, where they're essentially doing procedures/treatments that can't be done on U.S. soil- so they're doing um in places like S. America, Central America, Mexico, etc- and again, cash on the barrel, and fairly large amounts of cash needed ($10K a pop, is numbers I've seen in patient video/testimials/complaints made on Youtube, the 60 minutes piece, etc). They appear to have set up, or at least partnered with several "group" - gotta find the PR, that says they run 5 or 6 "sub companies" or whatever- and they "arrange" for a person to be "linked" I guess to one of these foreign country "doctors" for all kinds of "treatments" (if that's what one wants to call them IMO).
When I saw those PR's and read up on that "group" - they look to be, IMO, nothing much more than a web site, a lot of low budget videos, a rented "suite" and then pretty vast "claims" IMO- of all kinds of "cures/treatments" for nearly every malady known to mankind. I watched some of the videos- some of the funniest stuff I've ever seen- honestly. The one dude sits behind this desk with an old radio style microphone and supposedly "interviews" the two guys (it says like arthritis today or something"- and he asks some real lame (my opinion) question- and the one dude will start answering- and says like literally 10 words of nothing, then they fade and go to the next question, wash, rinse repeat. Baldness, erectile dysfunction- it was really funny. Let me see if I can link to it here- and these are again, "partners" or something per some PR. Really weirdo-rama stuff IMHO (mine OPINION only).
Here it is- these guys. I'm sorry - but I just can't take it seriously IMO. It looks like a web site, a rented suite maybe, a few people and the name "GLOBAL" of course- just doesn't pass my smell test. That's MY OPINION ONLY.
http://www.bioheartinc.com/assets/press/Globalstemcell.pdf
http://www.stemcellsgroup.com/
Now- watch this video- it just cracked me up, but hey, maybe that's just me? This is I guess- one of their, I guess 5 or 6 "sub" companies? Regenstem. It's funny as heck IMO- baldness, ED, autism, COPD, MS- I mean, it'll cure anything on the planet I guess? Me personally- I'd be nervous about these guys working on my car or recommending a mechanic to me- but hey, that's just me and that's just my 2 cents only.
"The trials on the .gov website state COPD, and that it has January 2016 "
So what, is my opinion. The MARVEL trial- the big ole, "flagship", Myocell, phase II/III trial is listed their too - and guess what? It says that "final data" was to be "complete" as of Feb. 2014.
http://clinicaltrials.gov/ct2/show/NCT00526253?term=bioheart&rank=1
That's MARVEL- and it's there and you know what, according to the 10-K it's gone/going nowhere. But says on the .gov site, "Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)"
Also- read the language carefully- it's a "study" versus a "trial" - big, big difference. A "study" is the baby step, loooong before you ever enter a serious trial- phase I, phase II, phase III, etc. Years and yrs before anything can even remotely happen from a commercial stand point IMO. Again, it's a big whoop IMO. (open label, non randomized- it's a no biggie IMO)
Well, the MARVEL trial has gone nowhere since about 2010. So big whoop it's "listed" on the .gov site. Read the 10-K, that's what matters. Be looking for all these "studies" and "trials" in coming 10-Q's and 10-K's and see what it says then- as to their progression or whatever.
What's mostly being listed right now are "studies"- which don't mean a whole lot IMO. So, lets say it actually does complete in Jan 2016 or whatever date in 2016. Then what? You'd now need a phase I, phase II and then a phase III to be even remotely close to ever bring it to market as an actual FDA approved "treatment"- probably 5 more yrs at least. So, 2021?
How bout the phase III trials right now- the ones that appear to be going nowhere? Who cares about more "studies" and that they are "listed" on the .gov site? When you got 3 people, and little to no money- what difference does it make? They can't even fund the actual, fairly decent trial- that might actually have a shot at progressing to "maybe" getting in front of the FDA one day. So why scatter-shot across a bunch more stuff? Money is already tight- why blow more on stuff starting back at square one when you can't even move the "flagship" product out of the holding pattern?
Makes zero sense to me as business plan. My personal opinion- it's nearly all just about "PR" and putting out a lot of it. It's not new for them- I've read stuff going back to 2009, reams of "deals" and "studies" and "new this and that" and "this will mean big sales" and blah, blah, blah. None of it, for the most part- even still exists today- or even gets a passing mention. Just like MIRROR didn't even get a "barely mention" in the latest 10-K. That should concern people far more than some recent "PR" about some "study" in Mexico, IMO.
That's the way I see it.
It's not a 10-K, that's filed for the increase in allocated share announcement, a 10-K is the end of yr, SEC filing annual report.
What was filed was known as a form 14 (14C) I believe- a "proxy" filing.
Don't know about the claim it's had "zero" effect on the share price? The stock has been 5 days now under the 50 DMA, and hasn't come close to breaking it once. It's in a down trend and volume is decreasing, drying up.
3 days is nothing. Just wait till more dilution occurs. Give it a few months. The share count, just from the 10-K release date was 420 million; by the filing of the form 14, it was stated as 460 million. Shares are pouring out like water IMO. Claiming 3 days as a "data point" is a stretch IMO.
One day, of one major seller- like an AHSER needing to unload, or go short, and this will be at 2 cents so fast, one's head will spin off IMO. It's already touched as low as about 2.5 cents. It's 65 plus percent off the .08 high that was only about 6 weeks ago.
The price has not "gone up" the last three days. It's flat at best, and on down days has been on higher vol. It's known as "making lower highs" and "lower lows"- a downtrend. Vol is key too. Look at a close like today- the broker dealer just "walked it up" to make it look like an "even" close- it could have been a $200 order or whatever. When it goes down, it goes down in big vol swings- and the volume sky rockets.
A day like today, about 1 million shares at 3 cents, that's about $30K traded all day. That's like having qty-15 people trade $2K of stock each. It's noise level.
Give it time- the dilution is not abating IMO, and key people, IMO are heavily manipulating this stock (broker/dealers and most likely one or more "finance" houses who are holders of convertibles and/or warrants)- that's my opinion. 3 days- I wouldn't get all worked up. Give it time. It can be at 2 cents in a blink on this one, that's the historic norm. One "big boy" going short, or needing to unload and down it will go- there is very little buy support IMO. Just low vol right now. It's heading on 7 days or so, and hasn't made it back over the 50 DMA avg once- not a good sign IMO. And that's despite a barrage of PR blasts and all- hasn't budged it at all.
Give it time IMO.
"STUDY"?? Wow, big whoop IMO. And this is supposed to lead to what, while the ole MIRROR phase III has gone silent and MARVEL went dead in the water and on and on and on? (COPD, ortho stuff, ED, animal stuff of all things- how bout just toss the entire kitchen sink at it and see what sticks mode, that's it IMO)
A "study"- that means 5 yrs minimum to even remotely = anything. Probably 7 to 10 yrs more likely for ever reaching something like an FDA approval.
Whatever happened to the "HEART", as n BioHEART? Funny, all the heart "trials" that ever mattered have amounted to nothing and myocell isn't even on patent protection anymore.
Notice too, the "PR BARRAGE" doesn't do anything to the price lately? They, IMO, have worn out the PR "about something" campaign- to where it's basically noise IMHO. You eventually reach saturation IMO, and it just becomes too much- 3 people doing all this "stuff"? Really?
Read the COPD one today- as vague as can be as always and says practically nothing IMO.
For example, states "the study" done at some "time before"- but doesn't say how many people, etc
And now it's extremely carefully worded to say will enroll "up to 100 patients" That wording is classic IMO. If one has any engineering or mathematics or probability/stat background; here's what those words mean. It means if "the study" ends up having ONE patient or TWO or FIVE for example, then they've made a true statement- because it's greater than zero patients and under 100. So, literally having ONE patient in said "study" would make the PR true.
A more typical wording IMO, would be, "The study will enroll a minimum of 50 patients to as many as 100 patients maximum"- that IMO now means something.
Also, it's another Mexico , non FDA type "deal" using this non-profit, self created "group" (whatever you want to call them) called the ICMS. They have no govt. regulatory or other authority like the FDA to "approve" or otherwise commercialize a product in the U.S, that I am familiar with? In fact the FDA just audited them not that long ago- questioning some of their practices- here are links to the FDA audit.
http://www.cellmedicinesociety.org/attachments/415_FDA%20483%20-%20ICMS%20IRB%20-%2019%20June%202012%20(redacted).pdf
http://www.cellmedicinesociety.org/component/content/article/86-news/415-fda-audit-findings
http://www.cellmedicinesociety.org/component/content/article/414-fda-audit
Further, what's "funding' all these "studies" (what, like half a dozen now, in fields all over the map, and not the "heart")- and the end game is what? What is all this supposed to lead too, besides generating nice sounding "PR" IMO? You can't even fund your key trials, some sitting dead in the water now for going on 4, almost 5 yrs and your own documents state "funding" as the cause- so you head off of your core-focus into a smattering of all kinds of other undertakings? That's the business "plan"? Make zero sense to me, IMO. My opinion. Mine only. Does nothing for me- just see it as "PR" and stuff that will probably never be heard about in a year or so, like so, so many of their past "PR" big "announcements". That's the way I see it.
I can't even count how many "PR" that is in what, like two weeks- and the share price is sitting at 3 cents and below. Oh well IMO. Doesn't seem to be generating any real excitement I can see IMO. I think it's the "where's the beef" time. As in show the phase II/III, FDA trials advancing, or else- what's the end game here? That's what I'm seeing. Studies, they're everywhere and most never lead to, or ever amount to anything being "commercialized" or monetized- they need money, and sales and cash and they need it now, not 7 to 10 yrs from now or whatever. Again, that's my opinion.
PR on 2 BILLION share increase, SEC filing "proxy"- still haven't found or seen it yet? Can't see it anywhere? Did the PR ever come out?
Saw the PR about some "study" on COPD or something? That one made it right out? Kinda weird IMHO?
How come the "news" that the outstanding shares are going to essentially double to 2 BILLION didn't make it onto the ole "PR" circuit?
Wonder how come some "stuff" gets big PR, but others never make it on PR? Again, just weird IMHO?
I've looked all over- and if it wasn't for that pesky ole SEC filing site- I don't think that form 14, Proxy announcement (whatever it's called exactly) would have ever been seen IMO.
The Beaumont hospital SEC form 8 filing or whatever it was called - that one got a big ole PR too, and "tweets" and all kinds of "news". It was a ole SEC filing, correct? So what happened to this Form 14, 2 BILLION share announcement news? Seems kinda like something pretty important that the ole common shareholders would really wanna know about IMO. Just odd IMHO?
Oh well, that's my opinion. I was looking for a PR on that 2 BILLION share announcement - after reading all the stuff about how it "should" mean lots of great stuff and all. Just haven't found that PR though? Oh well, will keep watching for it I guess. The COPD "study"- boy, that PR sure got out there fast, eh? But the 2 BILLION share "news" just didn't make it I guess?
"BHRT Bioheart's leading product, MyoCell, is a .."
is no longer under patent protection.
Previous 10-K to this year's (filed 3/29/13, PAGE 16:
"Patents and Proprietary Rights
We hold limited patent rights in our product candidates. Our MyoCath product candidate is protected by a patent, expiring in September 2017, in which we have an irrevocable co-exclusive license. Our MyoCell product candidate is no longer protected by patents, which means that competitors will be free to sell products that incorporate the same or similar technologies that are used in MyoCell without infringing our patent rights. As a result, MyoCell, if approved for use, may be vulnerable to competition in the form of products that use the same or similar technologies. We have previously licenses certain patents and patent applications relating to our MyoCell product candidate. These licenses have all lapsed as of the date of this report, although we have had discussions with the relevant licensor regarding a potential reinstatement of our rights in such licenses."
"Bioheart has initiated this new study for COPD"-
BHRT "initiates" a lot of things in PR's, etc IMO. Read the last 5 yrs of "PRs" - that's my suggestion, start around 2008 and just read um all. Google is an amazing tool. I've read probably every last "announcement" and notice of a "study" or "breakthrough" or "partnership" or "term sheet" or whatever, going back to at least 2008 or so. And today- it's a 3 cent stock, near cash broke, essentially no sales, no products even close IMO to commercialization under an FDA approval, 3 employees left, at least qty-3 CEO's since 2008, most of the BOD from the IPO time period gone, and the stock from 2008 to today- diluted from maybe 20 million shares tops, to now 460 MILLION or more shares.
COPD "study"- big whoop IMHO. Doesn't do it for me. Any word on MIRROR? ANY? Yeah? Any word on "reinitiating" MARVEL trial- it needs "reintiation" cause it's "stopped" and gone/going nowhere. Any "news" on that? Yeah.
Most, if any, never lead or amount to anything. They got phase II/III "trials" going back 5 yrs, sitting "parked" going nowhere.
How long does one think a "study" in COPD is from "commercialization"- realistically? What, 5 yrs at the very least, 10 yrs or so would be more the FDA industry "norm" IMO.
SO what IMO. And what is going to pay for advancing this "study" if it ever even gets finished, let alone advances to anything?
Founded in 1999, NO KIDDING??
Wow, that's only the 8th time, I've read those words, VERBATIM, in less than what, 6 days now?
WOW, amazing. And it's supposed to mean what?
Sorry, not impressed. Any fresh facts or ideas out there? Or, does one need to read this 20 more times to make sure all know it was "founded in 1999".
How bout this- it's been STRAIGHT DOWN since one of the worst IPO's in stock market history, and is now about a 3 cent stock. Down about 99% from 2008/2009 IPO date to today. No, there's no decimal missing, it's lost 99% of its value (actually a little more). That's not in 1999, that's from 2008 or so to today, modern actual historical facts.
http://venturebeat.com/2008/02/19/three-yards-and-a-cloud-of-dust-bioheart-makes-it-across-the-ipo-goal-line-but-with-little-to-show-for-its-struggles/
http://venturebeat.com/2007/10/12/i-told-you-so-eat-your-bioheart-out/#comments
Sounds like the only one using the SCAM word and "implying" anything is you.
Point out anywhere the post I made stated "scam", anywhere?
"One would think KC would consider working at another company"??
She and Tomas just got handed enormous base salary, plus total compensation package increases, despite their stock's performance being dismal IMO, return on investment to shareholder's being dismal IMO, etc. Why leave- why not milk the gig for as long as possible- if shares can continue to be diluted enough to keep some money trickling in as it appears to have been for several yrs now (20 million shares out in about 2010, to now 460 million plus shares total outstanding as of today), why not IMO? It's not that uncommon IMO, especially in penny stock land- "taking care of your own". Two people in the company, their base salaries alone, consume nearly the same amount that was spent on the entire budget last yr for "R&D" (think "trials" and so forth).
See salary and bonus table, most recent 10-K, PAGE 71.
Tomas has upped his annual, total comp package to nearly $1 MILLION a year on a company with a $12.5 million total market cap, and loaded with debt compared to that dismal, $12.5 millin market cap.
Comella, just got about a 50% yr over yr base salary increase- and now a total yearly compensation package equal to $366K. Why leave IMO?
Just those two and their base salaries $159K (comella) + $391K (tomas) = $550K annually.
10-K, PAGE F-4 (balance sheet entries)
R&D (Research and development) expense line entry for entire yr 2013 was $626,983. That's it, total. About $600K.
$550K base salary for two people versus total spent on all R&D, for what is touted as a "development stage, R&D company) was only about $600K, just a bit more than just the base, annual salaries for those two people. That's not including bonuses and "other" compensation- which puts um, those 2, far above what was spent on "R&D".
Anyone who doesn't see a problem with that, IMO is wearing the ole rose colored glasses. It's lopsided by any biz metric, SG&A to R&D spending ratios I'm familiar with- especially for a 3 person "company" who rents an office "suite" of about 5000 sq-ft and about $60K a yr in total lease payments (see 10-K, it's all there). That's my opinions.
"Over 100 million was spent by 2011 "? Why make statements with no factual references, when every last detail, regarding capital sunk to date, stock holder equity, return on equity (there is none in this case), etc is in a document known as the SEC filed 10-K?
Latest 10-K, PAGE 26:
"We are a development stage life sciences company with a limited operating history and a history of net losses and negative cash flows from operations. We may never be profitable, and if we incur operating losses and generate negative cash flows from operations for longer than expected, we may be unable to continue operations.
We are a development stage life sciences company and have a limited operating history, limited capital, limited sources of revenue and have incurred losses since inception. Our operations to date have been limited to organizing our company, developing and engaging in clinical trials of our MyoCell product candidate, expanding our pipeline of complementary product candidates through internal development and third party licenses, expanding and strengthening our intellectual property position through internal programs and third party licenses and recruiting management, research and clinical personnel. Consequently, it may be difficult to predict our future success or viability due to our lack of operating history. As of December 31, 2013, we have accumulated a deficit during our development stage of approximately $118.2 million. Our MyoCell product candidate has not received regulatory approval or generated any material revenues and is not expected to generate any material revenues until commercialization of MyoCell, if ever. Since inception, we have generated substantial net losses, including net losses of approximately $3.1 million, $4.0 million, $4.7 million, $5.2 million, and $4.4 million in 2013, 2012, 2011, 2010 and 2009, respectively and substantial negative cash flows from operations. We anticipate that we will continue to incur significant and increasing net losses and negative cash flows from operations for the foreseeable future "
And, same, most recent 10-K, PAGE F-2, the auditor's commentary:
"The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company is in the development stage, and has incurred net losses of $118,180,983 since inception. In addition, as of December 31, 2013 the Company’s current liabilities exceed its current assets by $13,362,480. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty."
And same 10-K, PAGE F-3: The balance sheet entry:
Shareholder's deficit entry: (118,180,983) (parenthesis of course equal a negative number).
That is the "paid in capital" deficit. $118 million. And what's left to show for it? A 3 cent stock and 460 plus million shares outstanding, a lot of current debt, and a 5 yr chart that's essentially straight down from the IPO date to present. Not sure IMO what's to "celebrate" here or deem a "success" by any stretch of the imagination IMO? By all normally excepted biz standards- it's a near, total bust IMO. That's just the way it is. Any biz person reading the financial history, the current "financials" etc would, I believe, say the same thing- it's in dire shape.
Further - in what, 5, 6 yrs tops maybe, you've gone through 3 or 4 CEO's I believe (can link to all names/announcements if needed), plus a mass exodus of nearly all former BOD members, several major Sr mgt change overs, loss of nearly all employees from a period when there were many, to now 3 total. Hardly a raving "success" story by any stretch I'm familiar with, and IMHO? Don't see it- not in the slightest.
"With cold hard stock options,"? I've never, ever known a consultant who would work "pro bono" for no cash, base pay rate and take "options" (which may, or may not end up worthless), especially on a 3 cent, sub 3 cent stock.
No way, not in my opinion. I've been inside companies who's stock was so hot- it was nearly as good as gold at the time and consultants, consulting "firms" only want cash/contracted rates. Period. And that "golden stock", as in "options" ended up underwater, worthless for most who ever received them, when the stock market took a dive. Look at the history of BHRT "options" going back as far as you want- they'd have nearly all, if not all, expired 100% worthless, as the stock has been a straight down, nose dive from the IPO date, to today.
"Options" don't = money or a certain payment. Options are a gamble on some future event. Even if you grant them "in the money", as of today, if the stock falls tomorrow- they're not worth the paper they're printed on.
No consultant/consulting firm I've ever known would take "options" as up front payment for any work to be performed. They have a going rate you pay for their expertise, they're "hired guns" in every classic sense of the word. They demand top dollar compared to their peers- and they get it, because they deliver results. And hiring um takes money, cash money in my experience and my opinion.
BHRT is "cash poor" - by their own SEC filings. It appears even the few, key employees left may already be foregoing taking salaries- due to lack of cash to pay them, as the 10-K indicates they are owed "loan" or "back payments" (paraphrasing- I can site exact 10-K page number). So if there is not even adequate cash flow to pay them- then what are high dollar consultants going to get paid with?
That's my opinion and the way I see it. Three people total- for a high technology bio-tech biz conducting FDA level phase II/III level trials and supposedly "international" biz dealings and more? My local, very small size Starbucks or my dry cleaner has more than 3 employees, as does my dentist office or the local auto repair place or my local pizza joint/chain- and they are considered micro-micro size businesses, not public stock traded companies. Come on, get real IMO.
" let us know in the upcoming blog."
My opinion- if it's not in the SEC filed 10-Q/10-K or similar SEC document- it doesn't matter to me what it says. That's my opinion.
Look at the PR about "adding to the team" and then a few months later - the reality in the 10-K, is it's down from 5 to now 3.
As to outsourcing- you still need a sizable "core" group who still work for the company- in every instance I've ever been involved with. Consultants and similar need to be managed, as do projects, etc in order to be in compliance with the way the company wants business done, done to the company's core standards and internal policies, etc. The more you outsource- the more time you need for project mgt, meetings, oversite, etc. "Outsourcing" isn't some magic word, panacea "fix all" that just runs on auto-pilot; not by a long shot IMO and experience. Some of the worst projects ever boned up, were done so at the hands of "consultants"- they are legendary in industry.
One employee is the CEO- he is also acting as the chief financial officer among other things/duties per the way he signs off on the SEC docs. 2n'd is Comella CSO who is what, doing "webinars" and "talks" and "conferences" and what- actually running/managing FDA level trials AND overseeing R&D as the CSO all at the same time? Really? In the end- the "employees" are 100% responsible for compliance, regulatory, signing off on everything, etc- you can't pass off/pawn those responsibilities off via simply stating, "we used consultants, it's their fault". Doesn't work that way. You still need a "core" company behind the "outsourcing".
Further, as stated- what are they paying these "consultants" with? Seen the cash realities? I don't think consultants work for penny stock shares, like some of the other "deals" that have been done per the 10-K and similar documents. Most I've ever known want cash, and cash being paid on time. That's my opinion.